24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
100% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
71.82% |
|
ATSTP10 SUCROSE TRANSPORT |
12.42% |
|
ATSTP10 TRANSPORT SIMULATION |
9.09% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
6.67% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
55.84% |
|
INFLUENZA |
8.81% |
|
CANCER |
7.85% |
|
ENZYME DYNAMICS |
7.47% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
4.7% |
|
ANTIBODY DYNAMICS SIMULATION |
4.42% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
3.05% |
|
RCA STABILITY SIMULATIONS |
2.77% |
|
RCA OLIGOMER STABILITY MD SIMULATIONS HEAT STRESS |
1.31% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
1.3% |
|
MEMBRANE TRANSPORT |
.83% |
|
ATSTP10 SUCROSE TRANSPORT |
.58% |
|
ATSTP10 TRANSPORT SIMULATION |
.42% |
|
RCA OLIGOMERIC STABILITY HEAT STRESS SIMULATIONS |
.38% |
|
SUCROSE TRANSPORTER ATSUC1 |
.27% |